Accelerometer Cut Points for Physical Activity Assessment of Older Adults with Parkinson's Disease

PloS One
Håkan NeroMaria Hagströmer

Abstract

To define accelerometer cut points for different walking speeds in older adults with mild to moderate Parkinson's disease. A volunteer sample of 30 older adults (mean age 73; SD 5.4 years) with mild to moderate Parkinson's disease walked at self-defined brisk, normal, and slow speeds for three minutes in a circular indoor hallway, each wearing an accelerometer around the waist. Walking speed was calculated and used as a reference measure. Through ROC analysis, accelerometer cut points for different levels of walking speed in counts per 15 seconds were generated, and a leave-one-out cross-validation was performed followed by a quadratic weighted Cohen's Kappa, to test the level of agreement between true and cut point-predicted walking speeds. Optimal cut points for walking speeds ≤ 1.0 m/s were ≤ 328 and ≤ 470 counts/15 sec; for speeds > 1.3 m/s, they were ≥ 730 and ≥ 851 counts/15 sec for the vertical axis and vector magnitude, respectively. Sensitivity and specificity were 61%-100% for the developed cut points. The quadratic weighted Kappa showed substantial agreement: κ = 0.79 (95% CI 0.70-0.89) and κ = 0.69 (95% CI 0.56-0.82) for the vertical axis and the vector magnitude, respectively. This study provides accelerometer cut ...Continue Reading

References

Oct 1, 1978·Seminars in Nuclear Medicine·C E Metz
Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·E D LouisS Fahn
May 19, 2000·Parkinsonism & Related Disorders·N GiladiA D Korczyn
Sep 19, 2000·Medicine and Science in Sports and Exercise·D R BassettG A King
May 16, 2001·Journal of Neurophysiology·C A McGibbon, D E Krebs
Jun 25, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S G TrostR R Pate
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Oct 27, 2004·Neurology·F Grandas, A Iranzo
Mar 3, 2005·Medicine and Science in Sports and Exercise·Ivy O W Man, Matthew C Morrissey
Jun 21, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Sonja von CampenhausenRichard Dodel
Jul 15, 2005·Medicine and Science in Sports and Exercise·Anthony G BrooksJohn L Plummer
Nov 19, 2005·Medicine and Science in Sports and Exercise·Gregory J Welk
Nov 19, 2005·Medicine and Science in Sports and Exercise·Charles E Matthew
Oct 19, 2006·Gait & Posture·Steven T MooreWilliam G Ondo
Aug 19, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Kirsten CorderUlf Ekelund
Mar 4, 2008·Journal of the American Dietetic Association·Samira FaresMaria Crotty
Mar 18, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·J Jankovic
Jun 7, 2008·Archives of Physical Medicine and Rehabilitation·Beth E FisherGiselle Petzinger
Oct 28, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Madaline B HarrisonG Frederick Wooten
Nov 27, 2008·Journal of Aging and Physical Activity·Leslie A PruittWilliam L Haskell
May 22, 2009·Acta Neurologica Scandinavica·M H Nilsson, P Hagell
Jun 27, 2009·General Hospital Psychiatry·Babak Roshanaei-MoghaddamJoan Russo
Oct 6, 2009·Archives of Physical Medicine and Rehabilitation·Robert W MotlYoojin Suh
Dec 31, 2009·Journal of Geriatric Physical Therapy·Stacy Fritz, Michelle Lusardi
Jan 29, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Jan LinderLars Forsgren
Feb 10, 2010·Medicine and Science in Sports and Exercise·Sarah L KozeyPatty S Freedson
May 5, 2010·Journal of Aging and Physical Activity·Nora E MillerSusan E Cashin
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
May 27, 2011·Journal of Neurology·Marlies van NimwegenMarten Munneke
May 28, 2011·Journal of Science and Medicine in Sport·Jeffer E SasakiPatty S Freedson
Jun 18, 2011·The International Journal of Behavioral Nutrition and Physical Activity·Teresa L HartScott J Strath
Jul 14, 2011·Nature Reviews. Neurology·Arlène D SpeelmanBastiaan R Bloem
Dec 23, 2011·Medicine and Science in Sports and Exercise·Patty FreedsonWilliam Haskell
Dec 23, 2011·Medicine and Science in Sports and Exercise·David R BassettStewart G Trost
Dec 23, 2011·Medicine and Science in Sports and Exercise·Nancy F ButteKlaas R Westerterp
Dec 23, 2011·Medicine and Science in Sports and Exercise·Dinesh John, Patty Freedson

❮ Previous
Next ❯

Citations

Jun 17, 2016·Expert Review of Medical Devices·Marco IosaGiovanni Morone
Apr 20, 2018·Physiological Measurement·Erik Reinertsen, Gari D Clifford
Sep 6, 2019·Current Neurology and Neuroscience Reports·Mikaela L FrechetteJacob J Sosnoff
Apr 8, 2020·Acta Neurologica Scandinavica·Brenda JengRobert W Motl
Nov 21, 2019·Movement Disorders Clinical Practice·Dong Wook KimNatalie E Allen
Oct 28, 2017·Gait & Posture·Matthew M EngelhardMyla D Goldman
Aug 7, 2021·Journal for the Measurement of Physical Behaviour·Scott J StrathJohn W Staudenmayer

❮ Previous
Next ❯

Software Mentioned

SPSS
ActiLife

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.